|
Press Releases |
|
 |
|
Saturday, August 24, 2024 |
|
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 |
Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of its COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1. more info >> |
|
Tuesday, March 26, 2024 |
|
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine |
Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher immune response against SARS-CoV-2 when compared to mRNA-1273.222, Moderna's licensed COVID-19 vaccine. more info >> |
|
Monday, December 11, 2023 |
|
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event |
more info >> |
|
Wednesday, July 5, 2023 |
|
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345 |
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older. more info >> |
|
Wednesday, May 3, 2023 |
|
Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines |
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an Enterprise Solutions Hub in the Philippines. The Moderna Enterprise Solutions Hub will provide business services across the Asia Pacific region, where Moderna currently has operations in six markets. Moderna also plans to establish commercial operations in the Philippines. more info >> |
|
Tuesday, September 13, 2022 |
|
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines |
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
Friday, September 9, 2022 |
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
Tuesday, July 19, 2022 |
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years |
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years. more info >> |
|
Thursday, February 17, 2022 |
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) |
Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years. more info >> |
|
Wednesday, February 16, 2022 |
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries |
Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company continues to scale up the manufacturing and distribution of its COVID-19 vaccine and future mRNA vaccines and therapeutics. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Mitsubishi Power Receives Contract for Large-Scale GTCC Project with 2,800 MW Total Output for Taiwan's Tung Hsiao Power Plant
Sept 5, 2025 21:47 JST
|
|
|
Hitachi announces historic $1 billion USD manufacturing investment to power America's energy future through production of critical grid infrastructure
Sept 5, 2025 21:00 JST
|
|
|
Fourth Paradigm announces 2025 interim results
Sept 5, 2025 18:25 HKT/SGT
|
|
|
Asia Unicorn Forum Releases 2024 Report: China, India, Israel Top Asian Unicorn Rankings
Sept 5, 2025 11:03 HKT/SGT
|
|
|
CBL International Reports 1H 2025 Results Highlighting Strong Biofuel Growth, Reduced Net Loss, and Improved Gross Profit Margin
Sept 5, 2025 10:36 HKT/SGT
|
|
|
NEC participates in Locked Shields 2025 hosted by the NATO Cooperative Cyber Defence Centre of Excellence
Sept 5, 2025 11:20 JST
|
|
|
LOLC Advanced Tech and Corsair Group Join Forces to Transform Waste into Fuel in Sri Lanka
Sept 5, 2025 07:00 HKT/SGT
|
|
|
TANAKA Announces Executive Appointment
Sept 5, 2025 3:00 JST
|
|
|
The MOU Signing Ceremony cum Seminar Titled "A New Horizon in Film & TV Trading: Web3 x DMP - Reshaping the Cross-Industry Supply Chain" Hosted by eBRAM Concludes Successfully
Sept 4, 2025 22:35 HKT/SGT
|
|
|
Magnum Opus Resorts Launches International Architectural Design Competition for Iconic Costa Rica Retreat
Sept 4, 2025 21:07 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates Historic Title Sponsorship of 2025 Pacific Coast Open at Santa Barbara Polo & Racquet Club
Sept 4, 2025 19:00 HKT/SGT
|
|
|
HKTDC Export Confidence Index: 3Q25; Exporter optimism rises as global trade tension falls
Sept 4, 2025 17:10 HKT/SGT
|
|
|
Zhejiang Expressway Absorbs and Merges with Oceanking Development: Establishing Dual A+H Platform to Boost Share Price
Sept 4, 2025 15:02 HKT/SGT
|
|
|
Fashion Hong Kong celebrates 10th anniversary, Four local brands present 'A Decade in Design: What is Seen? What is Felt?'
Sept 4, 2025 13:47 HKT/SGT
|
|
|
Honda to Begin Sales of All-new Prelude
Sept 4, 2025 13:20 JST
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|